CSL gives up on in-house vaccine
CSL has abandoned plans for a co-developed COVID-19 vaccine, but it will still be a key manufacturer.
PolyNovo chases new markets
Not content with healing wounds, this biotech is hoping to extend its technology to hernias.
Virgin Money UK: As bad as it gets?
Despite often trading at very low multiples, this UK bank has failed to deliver for shareholders.
CleanSpace: right place, right time
This maker of healthcare respirators is growing rapidly, but is there enough value on offer?
REA and Domain on the block
With these two property classifieds hitting new highs, we consider whether it's time to sell.
360 Capital updates its earnings outlook
360 Capital has updated its earnings forecast rendering its share price nonsensical to us.
The case for Omni Bridgeway
This litigation funder's obscure business model and quirky accounting belie its terrific track record and earning power. Is that the opportunity?
United Malt: Result 2020
With people consuming more beer at home during the pandemic, this malt producer's profits have suffered - but a decent business is hiding beneath the surface.
Altium on the front foot
The successful launch of its cloud product should help this PCB design software provider drive change in the electronics industry.
Adore gets a makeover
This freshly-listed online beauty retailer has a lot going for it. So why don't the owners want it?
ALE flashes its value
It's long been known that this property trust's pubs are rented at well below market rates. We now know by how much.
NAB: Result 2020
Like its peers, NAB is grappling with the pandemic but it can thank the government for keeping losses under control.
Lovisa's beeline to growth
The accessories retailer has fast-tracked its growth with an excellent acquisition at an unbelievable price.
Infratil's longer runway
For most businesses, Covid has either been a boon or a catastrophe. For Infratil, it's been both.
Model portfolio trades
The Intelligent Investor Equity Income portfolio is establishing two new positions.
OptiComm: 5 takeaways
With this fibre network owner's merger now complete, here are our takeaways as we move on to new opportunities.
Call 1300 880 160
Start a chat
Schedule a call
